Biography:
Darcy R. Tocci is PharmD candidate with an MBA from Johns Hopkins, focused on neuroscience, drug development, and biotech innovation. A Nucleate Activator finalist and venture fellow, she leads Neuro11 Therapeutics, a company developing first-in-class HDAC11 inhibitors for Alzheimer’s and other CNS disorders. Darcy has published research spanning space biology, neuroinflammation, and pharmacology, and is deeply involved in teaching, mentorship, and clinical training. She aims to advance transformative health technologies that meaningfully improve patient lives
Title : Neuropharmacological and regulatory drivers of tianeptine misuse in the united states: A growing public health concern